![Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis](https://www.spandidos-publications.com/article_images/or/38/2/OR-38-02-1035-g01.jpg)
Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis
CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer | Aging
CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer | Aging
CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer | Aging
![Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis](https://www.spandidos-publications.com/article_images/or/38/2/OR-38-02-1035-g02.jpg)
Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis
![The role of ubiquitination in tumorigenesis and targeted drug discovery | Signal Transduction and Targeted Therapy The role of ubiquitination in tumorigenesis and targeted drug discovery | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-0107-0/MediaObjects/41392_2020_107_Fig1_HTML.png)
The role of ubiquitination in tumorigenesis and targeted drug discovery | Signal Transduction and Targeted Therapy
![Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation | Nature Cell Biology Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation | Nature Cell Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fncb3228/MediaObjects/41556_2015_Article_BFncb3228_Fig1_HTML.jpg)